BioCentury
ARTICLE | Clinical News

Synovir thalidomide: FDA authorized a compassionate use protocol for expanded access to the drug, to include AIDS patients with cachexia who have opportunistic

September 5, 1995 7:00 AM UTC

Celgene Corp. (CELG), Warren, N.J. Product: Synovir thalidomide Indication: Cachexia (wasting) in AIDS Status: FDA authorized a compassionate use protocol for expanded access to the drug, to include ...